—
C+
C+ The full Closelook — membership. Open the C+ overview

Danaher Corporation (DHR) — chart, structure and Closelook read

Home› Indices›
Pick a ticker to load its detail page.

Company snapshot — Danaher Corporation

DHR in five paragraphs: what it makes and sells, where it sits in the Closelook stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
Danaher makes instruments, consumables and services used in biotechnology manufacturing, laboratory research and clinical diagnostics. Its Biotechnology arm supplies tools and materials that support drug development and production, including filtration, purification and single-use manufacturing equipment. The Life Sciences arm sells mass spectrometers, flow cytometers, microscopes, genomics tools and lab automation systems under brands such as Beckman Coulter, Leica Microsystems and SCIEX. The Diagnostics arm provides instruments and software that hospitals and laboratories use to test samples and guide treatment. It is based in Washington, United States, and has traded publicly since 1979.
Where it sits in the stack
Danaher carries no seat in our Rubin or Halo indices, so it sits outside the AI build-out stack the diary tracks there. It belongs to the Diagnostics & Research industry within our Healthcare sleeve, supplying tools that support drug development and clinical testing rather than compute infrastructure.
Who it is priced against
Closelook has not placed Danaher in a named peer group. The market often compares it with Thermo Fisher Scientific, another broad supplier of life-sciences and diagnostics equipment.
Why Closelook tracks it
Danaher is an S&P 500 constituent but has no Rubin or Halo index seat, and it has not yet drawn a Closelook score or a diary quote.
What the diary watches
Whether the diary picks up any of Danaher's diagnostics or life-sciences tools feeding into AI-driven drug discovery or lab automation, which would give it a route into the build-out sleeves it currently sits outside.

Danaher Corporation (DHR) trades on US exchanges.

Written from the company’s public profile and Closelook’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: DHR news on the tape · index compare · sector dispersion · scanner.

Signals for this name

Every Closelook reading that exists for DHR, from the same nightly bakes the boards use. Research diary readings, not advice.

Who it is priced against Diagnostics & Research · United States · 8 names with week and year-to-date

Peer group

Diagnostics & Research · United States

This name carries no Closelook score, so its cohort ranks on trend state — distance to the 50- and 200-day averages — never on a score it does not have.

Compared against DHR on the nightly bakes; the Peers tab ranks the cohort on the Closelook scores where it exists.

Dividends and capital return trailing yield 0.68%, quarterly · last 0.40 USD on 2026-06-26

Dividends and capital return

What DHR pays out and buys back — distributions read from the price series, money terms from the filings.

  • Trailing 12 months 1.44 USD per share · a 0.68% yield on the 2026-09-17 close 4 distributions, paid quarterly 2026-09-17
  • Change on the year +22.0% against the prior twelve months prior twelve months 1.18 USD per share
  • Last distribution 0.40 USD per share as the price series records it, within days of the ex-date 2026-06-26
  • By calendar year 2023: 28.66 USD (partial) · 2024: 1.08 USD · 2025: 1.28 USD · 2026: 0.80 USD to date first distribution recorded in the three-year window: 2023-10-02

Per-share amounts are derived from the adjusted price series in the listing currency, so dates sit within days of the ex-date; filing figures come from the fundamentals feed for the last reported fiscal year. An investment diary, not a recommendation.

Weather around the name 3 macro readings: Money Temperature, Factor regime, Sovereign pressure

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 55/100 · S&P 500 fund at 58, above its 50- and 200-day averagesEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-09-17
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 94th percentile of the window, +2.7% over 20 sessions. Factor regime → 2026-09-17
  • Sovereign pressure Index 0.00 · down 0.41 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-09-17

FAQ · from the current data · as of 2026-09-18

Quick answers

What is Danaher Corporation (DHR)?

Danaher Corporation trades as DHR on the US exchange (United States) in the Closelook research universe, as of the registry build of 2026-09-18.

Is DHR in a Closelook index?

Not currently — Danaher Corporation is tracked in the Closelook research universe but is not a constituent of a Closelook functional index as of 2026-09-18.

Where does DHR trade against its moving averages?

Bullish stack, 200-day still turning: Trades +4.4% vs the 50-day and +5.3% vs the 200-day average, 12.3% below the 52-week high and +32% off the 52-week low; a golden cross printed 5 sessions ago. Computed from daily closes. As of 2026-09-17 — a technical state from the nightly Closelook bake, not advice. The Technical tab carries the full row.

What does Danaher Corporation do?

Danaher makes instruments, consumables and services used in biotechnology manufacturing, laboratory research and clinical diagnostics. Its Biotechnology arm supplies tools and materials that support drug development and production, including filtration, purification and single-use manufacturing equipment. The Life Sciences arm sells mass spectrometers, flow cytometers, microscopes, genomics tools and lab automation systems under brands such as Beckman Coulter, Leica Microsystems and SCIEX. Closelook has not placed Danaher in a named peer group. The market often compares it with Thermo Fisher Scientific, another broad supplier of life-sciences and diagnostics equipment.

Where does Danaher Corporation sit in the AI build-out?

Danaher carries no seat in our Rubin or Halo indices, so it sits outside the AI build-out stack the diary tracks there. It belongs to the Diagnostics & Research industry within our Healthcare sleeve, supplying tools that support drug development and clinical testing rather than compute infrastructure. Danaher is an S&P 500 constituent but has no Rubin or Halo index seat, and it has not yet drawn a Closelook score or a diary quote.

Does Danaher Corporation pay a dividend?

Danaher Corporation has paid 1.44 USD per share over the last twelve months, paid quarterly, a trailing yield of 0.68% on the 2026-09-17 close; the last distribution recorded in the price series was 0.40 USD on 2026-06-26. The "Dividends and capital return" block on this page carries the lines.

What does this page show?

A live price chart with SMA overlays and drawing tools for DHR, performance metrics, index-membership context and the Closelook structure read — an investment research diary view, not investment advice.

Related in the Closelook universe

then Diagnostics & Research. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.